Nadia Aissaoui
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Nadia Aissaoui has a total of 52 co-authors. Here are the top co-authors by number of shared publications:
Jan Gummert
Heart and Diabetes Centre, NRW, Bad Oeynhausen, Germany
3 shared publicationsMichiel Morshuis
Heart and Diabetes Centre, NRW, Bad Oeynhausen, Germany
3 shared publicationsAlain Combes
2 shared publicationsAly El-Banayosy
2 shared publicationsBenoit Diebold
Georges-Pompidou European Hospital, Assistance Publique des Hôpitaux de Paris (AP-HP), Paris, France; Faculty of Medicine, University Paris Descartes, Paris, France; INSERM U 678, University Paris VI, Paris, France
2 shared publicationsEmmanuel Guerot
Georges-Pompidou European Hospital, Assistance Publique des Hôpitaux de Paris (AP-HP), Paris, France
2 shared publications
Latest Publications
- 1 September 2021
- Published by Elsevier in Australian Critical Care
- Vol. 34 (5) , 411-418
Prevalence of pressure injuries among critically ill patients and factors associated with their occurrence in the intensive care unit: The PRESSURE study
- 1 September 2021
- Published by Elsevier in Australian Critical Care
- Vol. 34 (5) , 411-418
Prevalence of pressure injuries among critically ill patients and factors associated with their occurrence in the intensive care unit: The PRESSURE study
- Open Access
- 22 October 2020
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 9 (11) , 3384
Hemodynamic Profiles of Cardiogenic Shock Depending on Their Etiology
The pathophysiology of cardiogenic shock (CS) varies depending on its etiology, which may lead to different hemodynamic profiles (HP) and may help tailor therapy. We aimed to assess the HP of CS patients according to their etiologies of acute myocardial infarction (AMI) and acute decompensated chronic heart failure (ADCHF). We included patients admitted for CS secondary to ADCHF and AMI. HP were measured before the administration of any inotrope or vasopressor. Systemic Vascular Resistances index (SVRi), Cardiac Index (CI), and Cardiac Power Index (CPI) were measured by trans-thoracic Doppler echocardiography on admission. Among 37 CS patients, 28 had CS secondary to ADCHF or AMI and were prospectively included. The two groups were similar in terms of demographic data and shock severity criteria. AMI CS was associated with lower SVRi compared to CS related to ADCHF: 2010 (interquartile range (IQR): 1895–2277) vs. 2622 (2264–2993) dynes-s·cm−5·m−2 (p = 0.002). A trend toward a higher CI was observed: respectively 2.13 (1.88–2.18) vs. 1.78 (1.65–1.96) L·min−1·m−2 (p = 0.067) in AMICS compared to ADCHF. CS patients had different HP according to their etiologies. AMICS had lower SVR and tended to have a higher CI compared to ADHF CS. These differences should be taken into account for patient selection in future research.
- 22 October 2020
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 9 (11) , 3384
Open AccessHemodynamic Profiles of Cardiogenic Shock Depending on Their Etiology
The pathophysiology of cardiogenic shock (CS) varies depending on its etiology, which may lead to different hemodynamic profiles (HP) and may help tailor therapy. We aimed to assess the HP of CS patients according to their etiologies of acute myocardial infarction (AMI) and acute decompensated chronic heart failure (ADCHF). We included patients admitted for CS secondary to ADCHF and AMI. HP were measured before the administration of any inotrope or vasopressor. Systemic Vascular Resistances index (SVRi), Cardiac Index (CI), and Cardiac Power Index (CPI) were measured by trans-thoracic Doppler echocardiography on admission. Among 37 CS patients, 28 had CS secondary to ADCHF or AMI and were prospectively included. The two groups were similar in terms of demographic data and shock severity criteria. AMI CS was associated with lower SVRi compared to CS related to ADCHF: 2010 (interquartile range (IQR): 1895–2277) vs. 2622 (2264–2993) dynes-s·cm−5·m−2 (p = 0.002). A trend toward a higher CI was observed: respectively 2.13 (1.88–2.18) vs. 1.78 (1.65–1.96) L·min−1·m−2 (p = 0.067) in AMICS compared to ADCHF. CS patients had different HP according to their etiologies. AMICS had lower SVR and tended to have a higher CI compared to ADHF CS. These differences should be taken into account for patient selection in future research.
- Open Access
- 14 September 2016
- Published by IntechOpen
Weaning Strategy from Veno-Arterial Extracorporeal Membrane Oxygenation (ECMO)
Weaning Strategy from Veno-Arterial Extracorporeal Membrane Oxygenation (ECMO) | InTechOpen, Published on: 2016-09-14. Authors: Nadia Aissaoui, Christoph Brehm, Aly El-Banayosy, et
- 14 September 2016
- Published by IntechOpen
Open AccessWeaning Strategy from Veno-Arterial Extracorporeal Membrane Oxygenation (ECMO)
Weaning Strategy from Veno-Arterial Extracorporeal Membrane Oxygenation (ECMO) | InTechOpen, Published on: 2016-09-14. Authors: Nadia Aissaoui, Christoph Brehm, Aly El-Banayosy, et
- 1 May 2015
- Published by Elsevier in Archives of Cardiovascular Diseases
- Vol. 108 (5) , 300-309
Assessment of right ventricular dysfunction predictors before the implantation of a left ventricular assist device in end-stage heart failure patients using echocardiographic measures (ARVADE): Combination of left and right ventricular echocardiographic variables
- 1 May 2015
- Published by Elsevier in Archives of Cardiovascular Diseases
- Vol. 108 (5) , 300-309
Assessment of right ventricular dysfunction predictors before the implantation of a left ventricular assist device in end-stage heart failure patients using echocardiographic measures (ARVADE): Combination of left and right ventricular echocardiographic variables
- 27 February 2015
- Published by Lavoisier in Réanimation
- Vol. 24 (2) , 183-190
Sevrage de l’ECMO (extracorporeal membrane oxygenation) veino-artérielle
L’oxygénation par membrane extracorporelle (ECMO) veino-artérielle est devenue l’assistance de premier choix dans le choc cardiogénique réfractaire. Les procédures de sevrage de cette technique d’assistance cardiocirculatoire largement répandue ne sont pourtant pas standardisées. Le taux de mortalité après un sevrage de l’ECMO reste élevé, ce qui montre que de nombreuses questions ne sont pas résolues dans ce domaine. Le but de cette revue est de proposer une stratégie de sevrage de l’ECMO veino-artérielle à la lumière des données de la littérature. Significant advances in extracorporeal technology have led to the more widespread use of veno-arterial extracorporeal membrane oxygenation (VA ECMO) for cardiac failure. However, procedures for weaning from VA ECMO are not standardized. The high death rate after successful weaning shows that many questions remain unresolved in this field. In this review, we discuss data from the literature and propose a strategy to optimize the weaning process.
- 27 February 2015
- Published by Lavoisier in Réanimation
- Vol. 24 (2) , 183-190
Sevrage de l’ECMO (extracorporeal membrane oxygenation) veino-artérielle
L’oxygénation par membrane extracorporelle (ECMO) veino-artérielle est devenue l’assistance de premier choix dans le choc cardiogénique réfractaire. Les procédures de sevrage de cette technique d’assistance cardiocirculatoire largement répandue ne sont pourtant pas standardisées. Le taux de mortalité après un sevrage de l’ECMO reste élevé, ce qui montre que de nombreuses questions ne sont pas résolues dans ce domaine. Le but de cette revue est de proposer une stratégie de sevrage de l’ECMO veino-artérielle à la lumière des données de la littérature. Significant advances in extracorporeal technology have led to the more widespread use of veno-arterial extracorporeal membrane oxygenation (VA ECMO) for cardiac failure. However, procedures for weaning from VA ECMO are not standardized. The high death rate after successful weaning shows that many questions remain unresolved in this field. In this review, we discuss data from the literature and propose a strategy to optimize the weaning process.
- 27 January 2015
- Published by Springer Nature in Intensive Care Medicine
- Vol. 41 (5) , 902-905
How to wean a patient from veno-arterial extracorporeal membrane oxygenation
- 27 January 2015
- Published by Springer Nature in Intensive Care Medicine
- Vol. 41 (5) , 902-905
How to wean a patient from veno-arterial extracorporeal membrane oxygenation
- 1 July 2013
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 146 (1) , 186-191
Temporary right ventricular mechanical circulatory support for the management of right ventricular failure in critically ill patients
- 1 July 2013
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 146 (1) , 186-191
Temporary right ventricular mechanical circulatory support for the management of right ventricular failure in critically ill patients
- 1 January 2013
- Published by Elsevier in Archives of Cardiovascular Diseases
- Vol. 106 (1) , 44-51
Heart failure while on ventricular assist device support: A true clinical entity?
- 1 January 2013
- Published by Elsevier in Archives of Cardiovascular Diseases
- Vol. 106 (1) , 44-51
Heart failure while on ventricular assist device support: A true clinical entity?